n - 3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects

American Journal of Clinical Nutrition

Volumn 63, Issue 2, 1996, Pages 261-266

  Bonanome, Andrea ^a   Biasia, Franco ^b   De Luca, Massimo ^b   Munaretto, Giorgio ^b   Biffanti, Susanna ^b   Pradella, Marco ^b   Pagnan, Antonio ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

Fatty acid; Hemodialysis; Hypertriacylglycerolemia; n 3 Fatty acids; Oxidized low density Iipoprotein

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FATTY ACID OXIDATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

AMIDINES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; MIDDLE AGED; RENAL DIALYSIS; TRIGLYCERIDES; VITAMIN E;

EID: 0030028066     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/63.2.261     Document Type: Article

References (41)

1. Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Avram MM, Fein PA, Antignani A, et al. Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Med 1989;87:5-55N-5-60N.
3. Nestel PJ, Fidge NH, Than MH Increased lipoprotein remnant formation in chronic renal failure. N Engl J Med 1982;307:329-33.
4. Rustemeijer C, Bilo HCG, Beukhof JR, Scheuten JA, Mulder C. Donter AJM. The effect of fish oil concentrate on serum lipids and lipoproteins in patients on maintenance hemodialysis. Curr Ther Res 1988;43:559-67.
5. Donnelly SM, Mahmoud AMA, Churchill DM. Effect of n - 3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc Nephrol 1962;2:1634-9.
6. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989;30:785-807.
7. Brown JE, Wahle KWS. Effect of fish oil and vitamin E supplementation on lipid peroxidation and whole blood aggregation in man. Clin Chim Acta 1990;193:147-56.
8. Harats D, Dobach Y, Hollander G, et al. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 1991;90:127-39.
9. Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, et al. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Arterioscler Thromb 1993;13:1790-7.
10. Berry E, Eisenberg S, Haratz D, et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins - the Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am J Clin Nutr 1991;53:899-907.
11. Reaven P, Parthasarathy S, Grasse BJ, et al. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr 1991;54:701-6.
12. Bonanome A, Pagnan A, Biffanti S, et al. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler Thromb 1992;12:529-33.
13. Steinberg D. Parthasarathy S, Carew TE, Khoo JC, Witztum JC. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-24.
14. Avogaro P, Bittolo Bon, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988;8:79-87.
15. Toborek M. Wasik T, Dròzdz M, Klin M, Magner Wrobel K, Kopieznu-Grzebiemak E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992;41:1229-32.
16. Paul JL, Sall ND, Soni T, et al. Lipid peroxidation abnormalities in hemodialyzed patients Nephron 1993;64:106-9.
17. Pastor NC, Sierra C, Bonal J, Teixido J. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis. Am J Nephrol 1993;13:238-43.
18. Roeschlau P. Burnt E, Gruber W. Enzymatic assay of cholesterol in plasma. (Enzymatische Bestimmung der Gesamt - Cholesterins im Plasma) Z Klin Chem Klin Biochem 1974;12:226(abstr).
19. Nagele V. Hagele EO, Sauer G, et al. Reagent for enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 1984;22:165-74.
20. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determinations in high density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
21. Lipid Research Clinics Program. Manual of laboratory operations. Vol 1, 2nd ed. Lipid and lipoprotein analysis. Washington, DC: US Government Printing Office, 1982.
22. Markwell MAK, Hass SM, Tolbert NE, Bieber LL. Protein determination in membrane and lipoprotein samples: manual and automatic procedures. In: Lowenstein JL, ed. Methods in enzymology. New York: Academic Press, 1981:293-303.
23. Niki E. Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 1987;44:227-53.
24. Christie WW. Gas chromatography and lipids a practical guide. Ayr. Scotland: Scotland Oily Press, 1989.
25. Bonvicini P, Molari A, De Besi T, Burlina A. Determination of vitamins by high performance liquid chromatography: II. Retinol and alpha tocopherol in serum. Prog Med Lab 1992;6:523-7.
26. Esterbauer H, Jürgens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr Opin Lipidol 1993;4:114-24.
27. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw Hill Book Co, Inc, 1981.
28. Conover WJ. Practical non-parametric statistics. 2nd ed. New York: John Wiley & Sons Inc, 1980.
29. Sullivan DR, Sanders TAB, Trayner IM, Thompson GR. Paradoxical elevation of LDL apoprotein B levels in hypertriglycendemic patients and normal subjects ingesting fish oil. Atherosclerosis 1986;61:129-34.
30. Huff MW, Telfard DE. Dietary fish oil increases the conversion of VLDL apo B to LDL apo B. Arteriosclerosis 1989;9:58-66.
31. Connor WE, De Francesco CA, Connor H. n - 3 Fatty acids from fish oil. Effects on plasma lipoproteine and hypertriglycendemic patients. Ann N Y Acad Sci 1993;683:16-34.
32. Gröne EF, Walli AK, Gröne HJ, Miller B, Seidel D. The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 1994;107: 1-13.
33. Jialal I. Grundy SM. Effect of dietary supplementation with alphatocopherol on the oxidative modification of low density lipoproteins. J Lipid Res 1992;33:899-906.
34. Bonaa KH, Bjerve KS, Straum B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. N Engl J Med 1990;322:795-801.
35. Lands WE. Biochemistry and physiology of n - 3 fatty acids. FASEB J 1992;6:2530-6.
36. Loughrey CM, Young IS, McEnemy J, et al. Oxidation of low density lipoprotein in patients on regular haemodialysis. Atherosclerosis 1994; 110:185-93.
37. Biffanti S, Bonanome A, Maiorino M, Ursini F, Pagnan A. Assay of low density lipoprotein susceptibility to oxidation by means of the free radical generator AAPH. Nutr Metab Cardiovasc Dis 1994;4:137-41.
38. Leaf A, Weber PC. Cardiovascular effects of n - 3 fatty acids. N Engl J Med 1988;318:109-17.
39. Von Schacky C. Prophylaxis of atherosclerosis with marine omega-3 fatty acids. Ann Intern Med 1987;107:890-9.
40. Knapp HR, Fitzgerald GA The antihypertensive effects of fish oil A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989;320:1037-43.
41. Kestin M, Clifton P, Belling BG, Nestel PJ. n - 3 Fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n - 3 and n - 6 fatty acids from plants. Am J Clin Nutr 1990;51:1028-34.